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Adherent-invasive Escherichia coli (AIEC) strains are detected more frequently within
mucosal lesions of patients with Crohn’s disease (CD). The AIEC phenotype consists
of adherence and invasion of intestinal epithelial cells and survival within macrophages
of these bacteria in vitro. Our aim was to identify candidate transcripts that distinguish
AIEC from non-invasive E. coli (NIEC) strains and might be useful for rapid and accurate
identification of AIEC by culture-independent technology. We performed comparative
RNA-Sequence (RNASeq) analysis using AIEC strain LF82 and NIEC strain HS during
exponential and stationary growth. Differential expression analysis of coding sequences
(CDS) homologous to both strains demonstrated 224 and 241 genes with increased and
decreased expression, respectively, in LF82 relative to HS. Transition metal transport and
siderophore metabolism related pathway genes were up-regulated, while glycogen meta-
bolic and oxidation-reduction related pathway genes were down-regulated, in LF82. Che-
motaxis related transcripts were up-regulated in LF82 during the exponential phase, but
flagellum-dependent motility pathway genes were down-regulated in LF82 during the sta-
tionary phase. CDS that mapped only to the LF82 genome accounted for 747 genes. We
applied an in silico subtractive genomics approach to identify CDS specific to AIEC by in
corporating the genomes of 10 other previously phenotyped NIEC. From this analysis,
166 CDS mapped to the LF82 genome and lacked homology to any of the 11 human NIEC
strains. We compared these CDS across 13 AIEC, but none were homologous in each.
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Four LF82 gene loci belonging to clustered regularly interspaced short palindromic repeats
region (CRISPR)—CRISPR-associated (Cas) genes were identified in 4 to 6 AIEC and
absent from all non-pathogenic bacteria. As previously reported, AIEC strains were
enriched for pdu operon genes. One CDS, encoding an excisionase, was shared by 9 AIEC
strains. Reverse transcription quantitative polymerase chain reaction assays for 6 genes
were conducted on fecal and ileal RNA samples from 22 inflammatory bowel disease (IBD),
and 32 patients without IBD (non-IBD). The expression of Cas loci was detected in a higher
proportion of CD than non-IBD fecal and ileal RNA samples (p <0.05). These results support
a comparative genomic/transcriptomic approach towards identifying candidate AIEC signa-
ture transcripts.
Introduction
Crohn’s disease (CD) is a form of inflammatory bowel disease (IBD) that is characterized by
skip lesions of transmural inflammation, and can occur at multiple sites in the digestive tract.
Inflammation can be found anywhere in the gastrointestinal tract from the mouth to the anus,
but in most (60–80%) CD patients, the distal small intestine is frequently involved [1, 2]. Fac-
tors implicated in the pathogenesis of IBD include host genetic predisposition, and continual
activation of the mucosal immune system by luminal bacteria and their products [3, 4]. From
16S ribosomal RNA gene sequence data, several laboratories have demonstrated imbalances in
the gut microbial composition of CD patients, particularly those with ileal involvement when
compared to unaffected individuals [5–16]. A consistent feature is a reduction in the relative
frequency of Faecalibacterium prausnitzii [8] and an increase in Proteobacteria, particularly
Escherichia coli [5]. A greater relative abundance of E. coli has been associated with CD, and
particularly in active disease compared to patients in remission [17]. Mucosa-associated E. coli
in particular are more abundant in CD [18] and in several small studies were isolated from
inflamed tissue that include areas with ulcers and granulomas [19, 20]. In addition E. coli from
the neoterminal ileum in post-surgical CD patients are linked to early recurrence of the disease
[2].
Adherent invasive E. coli (AIEC) are considered to be pathobionts [21–23] and are isolated
from the intestinal mucosa in humans with a higher prevalence in CD patients than in healthy
subjects [2, 24, 25]. The AIEC phenotype requires adherence and invasion of intestinal epithe-
lial cells and survival and replication within macrophages [26, 27]. Only a few commensal E.
coli have been tested for this phenotype [28]. Using these methods, AIEC strains are detected
in 22–52% of ileal CD patients and in 6–18% of non-IBD subjects [2, 18, 29–31]. However,
these studies differ with respect to the number of biopsies analyzed, the anatomical location of
the biopsies, and disease activity.
The design of a culture independent assay is hindered by the fact that although AIEC usually
belong to the B2 or D groups, they are phylogenetically heterogeneous [18, 32]. Jensen et al
[33] reported a quantitative real-time PCR (RT-qPCR) to determine the proportion of E. coli
LF82 in DNA from human intestinal biopsies using spiked samples, but has not reported the
results of this assay using clinical samples. Furthermore the genomic target of this assay, the
pMT1-like plasmid, is not conserved among AIEC. Dogan et al,[34] reported that genes encod-
ing processes responsible for propanediol utilization (pdu operon) and iron acquisition (yersi-
niabactin, chu operon) are overrepresented in human and dog AIEC genomes and might
represent AIEC virulence factors.
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To gain insight into biological pathways that contribute to AIEC pathogenicity we con-
ducted a comparative transcriptomic analysis of the reference AIEC strain LF82 and the non-
invasive commensal strain HS, grown in pure cultures. Furthermore, the genomic sequences of
11 non-invasive E. coli strains, including MG1655 [35] and HS [36], and a panel of 13 AIEC
strains [34, 37–41] were compared to identify coding regions that could potentially serve as
AIEC probes. Five of these gene targets and the previously described gene pduC, were tested by
reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) following extraction
of RNA from fecal and ileal biopsy samples from 53 patients with and without IBD.
Materials and Methods
Homology searches in AIEC and non-invasive E. coli genomic
sequences
The characteristics of seven previously published human AIEC (strains LF82, UM146,
NRG857c, HM605, 541_1, 541_15, 576_1) and three human NIEC (strains T75, HS and MG-
1655), are summarized in Table 1. Reference genomes were retrieved from NCBI [28, 34–41].
The characteristics of the six AIEC (strains MS-107-1, MS-115-1, MS-119-1, MS124-1,
MS145-7, MS57-2), and 8 NIEC (strains MS185-1, MS187-1, MS196-1, MS198-1, MS45-1,
Table 1. Characteristics of 13 human AIEC and 10 non-invasive E. coli isolates. The AIEC phenotype was assessed using gentamycin protection
assays of epithelial invasiona and survival within macrophages. The IBD affectation status was described as CD, UC or non-IBD. The anatomic site or source
was the ileum, colon or feces. The pathology if available was described as macroscopically unaffectred or diseased or was not documented (-). For feces, the
pathology was not applicable (N.A.) The K12-MG1655 strain was cured from K12 and has been maintained as a laboratory strain. The orginal K12 strain was
isolated from a patient suffering from diphtheria.
E. coli strain AIEC phenotype IBD affectation status Anatomic site Pathology Reference
LF82 AIEC CD ileum diseased [37]
NRG857c AIEC CD ileum - [38]
UM146 AIEC CD ileum - [40]
HM605 AIEC CD colon - [39]
541_1 AIEC CD ileum [34]
541_15 AIEC CD ileum [34]
576_1 AIEC CD ileum [34]
MS-107-1 AIEC CD ileum
MS-115-1 AIEC UC colon diseased
MS-119-7 AIEC CD colon -
MS-124-1 AIEC CD ileum unaffected
MS-145-7 AIEC CD colon -
MS-57-2 AIEC Non-IBD ileum unaffected
HS Non-invasive Non-IBD feces N.A. [36]
K12-MG1655 Non-invasive Non-IBD feces N.A.
T75 Non-invasive CD ileum - [34]
MS-185-1 Non-invasive Non-IBD colon unaffected
MS-187-1 Non-invasive Non-IBD colon unaffected
MS-196-1 Non-invasive Non-IBD colon unaffected
MS-198-1 Non-invasive Non-IBD colon unaffected
MS-45-1 Non-invasive UC colon diseased
MS-60-1 Non-invasive Non-IBD colon diseased
MS-78-1 Non-invasive UC colon diseased
MS-84-1 Non-invasive CD ileum unaffected
doi:10.1371/journal.pone.0130902.t001
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MS60-1, MS78-1, MS84-1) are also listed in Table 1. These MS strains were isolated from de-
identified surgical resection specimens collected at Mount Sinai School of Medicine [6] from
CD, UC and non-IBD patients and characterized with respect to AIEC phenotype. The
genomes of these 14 E. coli strains are accessible through the Human Microbiome Project data-
base [42]. Homologous CDS were compared for these 13 AIEC and 11 NIEC. A search was
also conducted among diarrheagenic (DEC) and extraintestinal (ExPEC) pathogenic E. coli (S1
Table) using the alignment tool BLASTN (version 2.2.28+). Homologous genes were defined as
those with85% sequence identity over 90 to 110% of the length of the query as previously
described [37].
Bacterial RNA isolation, sequencing and alignment to genomes
The reference AIEC strain LF82, originally isolated by Dr. Darfeuille-Michaud, was provided
as a gift by Dr. Phillip Sherman (University of Toronto) and its identity was confirmed by
multi-locus sequence typing[43]. The non-invasive HS strain was purchased from American
Type Culture Collection (ATCC 700891). Triplicate Luria broth cultures (37°C) of LF82 and
HS were grown with continuous shaking for 2 hours (exponential phase) and 24 h without
shaking (stationary phase). Total RNA was extracted from the cells using the RiboPure Bacteria
kit (Life Technologies Corp. Carlsbad, CA), following the manufacturer’s protocol. The average
RNA Integrity Number (RIN) over all samples was 7. Two micrograms of RNA was depleted
of ribosomal RNA using the RiboMinus Transcriptome Isolation Kit (Life Technologies Corp.
Carlsbad, CA). These samples were then used as a template for strand-specific cDNA synthesis
and subjected to single-end 150 bp Illumina sequencing. The RNA-Seq libraries were prepared
and sequenced at the New York Genome Center (NYGC). Raw sequences were filtered to
remove human sequence contamination, remove short reads (< 50 bp), depleted of duplicate
reads, and quality trimmed using Trimmomatic (v 0.32) [44]. rRNA sequences were identified
and culled using SortMe RNA (v1.9) [45]. Raw sequence reads for LF82 and HS were mapped
to NCBI reference genomes NC_011993 and NC_009800, respectively [37] using the Bur-
roughs Wheeler aligner (BWA) [46]. Counts for each annotated genomic loci were determined
by HTseq-count (version 0.6.1) [47]. The data discussed in this publication have been depos-
ited in NCBI's Gene Expression Omnibus and are accessible through GEO Series accession
number GSE69020.
Differentially Expressed Genes (DEGs) in LF82 compared to HS
Two DEG algorithms were employed, edgeR [48] and DESeq [49]. The raw counts produced
by HTseq-count provided the input variables for the DESeq and edgeR packages. DEGs were
defined as 2 fold change and FDR< 0.05 and LF82 and HS transcripts were compared at 2h
or 24h, independently. DEGs resulting from edgeR were the input variables for knowledge
based biological functions using the Gene Ontology (GO) plugin BiNGO [50] and the custom
ontology and annotation files found on the Gene Ontology website [51, 52]. DEGs resulting
from DESeq were the input variables for knowledge based pathways/modules defined either by
the Kyoto Encyclopedia of Genes and Genomes (KEGG, http://www.genome.jp/kegg/) [53] or
a set of modules obtained through clustering a network of high quality functional interactions
predicted for E. coli [54]. The up-regulated and down-regulated output from DESeq for each
time point were entered to identify the perturbed pathways regardless of the overall polarity.
Ethics Statement
This study was approved by the Institutional Review Board (IRB) at Stony Brook University
Hospital. Pediatric (age 7 years) and adult patients are recruited in a consecutive fashion by
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the Stony Brook Digestive Diseases Research Tissue Procurement Facility and provide verbal
and written consent for chart abstraction, blood, stool, tissue biopsies and/or surgical waste col-
lection with analysis for research purposes and for their information to be stored in the hospital
database. For children between 7–17 years old participating in this study, both oral and written
parent/legal guardian permission and a separate oral and written assent from the child was
obtained. The IRB at Stony Brook University Hospital approved this consent procedure.
Enrollment of patients and collection of samples
After receiving IRB approval, participants previously scheduled to undergo colonoscopy or
intestinal resection, were identified and consented. Pediatric (ages7 years) and adult patients
were recruited in a consecutive fashion by the Stony Brook Digestive Diseases Research Tissue
Procurement Facility. The period of enrollment was between March 2011 and June 2014.
Patients with a confirmed diagnosis of IBD were phenotyped based on endoscopic and radio-
graphic studies as previously described [55]. Tissue specimens were collected and immediately
placed into RNAlater (Life Technologies, Carlsbad, CA).
DNA isolation from bacteria
Nine bacterial strains were processed for DNA isolation: LF82, MG1655, HS, and 6 MS AIEC
strains. Following overnight culture, a single colony of each bacterial strain was placed in 5 ml
of tryptic soy broth and incubated overnight at 37°C with shaking. Total bacterial DNA was
extracted using the QIAamp DNAMini Kit and according to the manufacturer’s protocol and
stored at -20°C until batch analysis.
PCR and electrophoresis
The forward and reverse primers for the Cas genes (strains LF82_088, LF82_091, LF82_092
and LF82_093) were designed using the NCBI primer designing tool Primer-BLAST [56]. The
E. coli 16S rRNA forward and reverse primers were previously validated [57]. The predicted
PCR products were 340 bp for E. coli 16S rRNA, 107 bp for LF82_088, 109 bp for LF82_091,
97 bp for LF82_092, and 125 bp for LF82_093. Amplification was performed in a 15 μL reac-
tion volume and consisting of 1.5 μL 10X PCR buffer (Qiagen), 3 μL Q solution, nuclease free
water, 0.5 μM forward and reverse primers, 0.1 uL Qiagen Taq DNA polymerase, and 1μL tem-
plate. PCR was performed using an Eppendorf Mastercycler EPGradient S. The following ther-
mal cycling conditions were used: 5 min at 94°C and 36 cycles of amplification consisting of
30 seconds at 95°C, 30 seconds at 56°C, and 1 min at 72°C, with 5 min at 72°C for the final
extension. PCR product bands were analyzed after electrophoresis in a 1% agarose gel in 1X
TBE containing ethidium bromide and digital imaging using The ChemiDoc MP system
(Biorad, Hercules, CA).
RNA isolation from stool and bacteria
Total bacterial RNA was extracted from each stool sample using a fecal RNA isolation kit
(Zymo Research Corporation, Irvine, CA) according to the manufacturer’s protocol. RNA
from strains LF82, MG1655, and HS was extracted using the same kit after culture for 2 and
24 hours. RNA was archived at -800 C until batch analysis.
RNA isolation from ileal biopsies
Fresh frozen ileal biopsies were homogenized individually in 2 ml of Trizol solution (Life Tech-
nologies) with the PowerGen125 homogenizer (Fisher Scientific) and 1 ml aliquots placed into
Candidate Signature AIEC Transcripts
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1.5 mL microcentrifuge tubes. RNA was subsequently extracted using phenol/chloroform
extraction methods as previously described[58]. The RNA was reconstituted in 50ul of RNA
Storing Solution (Life Technologies) and stored at -800 C until batch analysis.
Reverse transcription quantitative polymerase chain reaction (RT-
qPCR) of E. coli transcripts
For cDNA production, 500 nanograms of RNA was added to a 20 μL reaction using the Super-
Script VILO cDNA Synthesis Kit (Life Technologies, Carlsbad, CA). Quantitative PCR was
conducted in triplicate on 1:2 dilutions of cDNA from fecal samples and 1:2, 1:4 and 1:8 dilu-
tions of cDNA from pure E. coli cultures and using 1 μL volumes. Amplification was performed
in a 20 μL reaction volume and consisting of 10 μl of 2x SYBR Green Master Mix, 1 μl each of
10uM forward and reverse primers, 1 μL of cDNA, and 7 μL of nuclease free water. The ther-
mal cycling conditions were: 10 min at 95°C and 40 cycles of amplification consisting of 30 sec-
onds at 95°C and 60 seconds at 60°C using a Mastercycler EPGradient S (Eppendorf). Primers
included Total bacteria and E. coli 16S rRNA forward and reverse primers as previously vali-
dated [57] and the pduC gene as previously described [34]. Primers were designed for 5 candi-
date genes LF82_088, LF82_091, LF82_092, LF82_093, and LF82_095, using an online primer
design tool[56]. The sequences of all primers are listed in S2 Table.
Statistical analysis
All analyses were performed using the GraphPad Prism 5 software suite (GraphPad, San
Diego, CA). For each RT-qPCR assay, the average cycle threshold (Ct) of 3 replicates per gene
was determined. Positive assays had a mean threshold cycle values (Ct)35. The Ct values in
negative samples and water ranged from 39–40. Fisher’s exact test was performed to compare
positive and negative counts in IBD compared to non-IBD and CD compared to non-IBD, for
fecal and ileal biopsy samples, respectively. The relative abundance of E. coli 16S rRNA tran-
scripts was determined by defining the delta Ct (ΔCt). ΔCt was generated by subtracting the
average Ct value for total bacteria away from the average Ct value of E. coli 16S rDNA. The
nonparametric Mann-Whitney test was used to compare values for IBD compared to non-IBD
and CD compared to non-IBD for fecal and ileal biopsy samples, respectively.
Results
Identification of differentially expressed genes (DEG) in LF82 vs. HS
We analyzed gene expression levels of strains LF82 and HS in separate samples prepared from
exponential (2h) and stationary (24h) phase cultures grown at 37°C, in order to interrogate
gene expression under different growth conditions. Expression levels were standardized by
reads per kilobase of exon per million mapped sequence reads (RPKM) [59]. The edgeR and
the DESeq algorithms yielded similar findings. Results generated using edgeR are shown in S1
File. For the 2h and 24h samples, 654 and 459 CDS, respectively, had increased expression
(RPKM2 fold, FDR<0.05) in LF82 compared to HS (Table A in S1 File), with 224 of the
CDS exhibiting increased expression in LF82 at both time points. At 2 h, 6 genes shared by
LF82 and HS were expressed only in LF82. Similarly at 24 h, 17 genes had detectable transcripts
in LF82 and not in HS (Table A in S1 File). Six genes were detected only in LF82 at both time
points. Some of these genes are involved in bacteriophage infections and others have no known
function (Table 2). A total of 712 and 492 genes had decreased expression at 2h and 24h
respectively, in LF82 compared to HS (Table B in S1 File), with 241 genes exhibiting decreased
expression in LF82 (RPKM 0.05, FDR<0.05) at both time points.
Candidate Signature AIEC Transcripts
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Functional profiling of genes was accomplished using the Gene Ontology (GO) plugin
BiNGO [50] and the custom ontology and annotation files on the Gene Ontology website
(http://www.geneontology.org). This analysis revealed that multiple functional categories have
overlapping datasets as shown in Tables A-D in S2 File. Examples include “siderophore meta-
bolic process like enterobactin”, which are up-regulated at both time points, and”glycogen met-
abolic process” and “oxidation-reduction process”, which are down regulated at both time
points (Table 3). Analysis using alternative pathways/modules gene sets [53, 54] facilitated
visualization of patterns of gene expression against a very complex background. For example,
the functional category chemotaxis is up-regulated (FDR = 0.008) in LF82 at 2h, but bacterial-
type flagellum-dependent cell motility is down regulated (FDR = 1.4 x 10−6) at 24h. However
as shown in Fig 1, the polarity of the DEGs are preserved at both time points. These network-
based results draw attention to modules that do not overlap with the GO categories (e.g. mod-
ules 24 and 79 in Fig 1).
Table 2. These 6 CDS are homologous in LF82 and HS but transcripts are detected only in LF82 at both 2h and 24 h. The LF82 NCBI Locus Tags and
the bacterial gene names (if available) are shown. The mean normalized RPKM at 2h and 24 h is shown.
LF82 NCBI Locus
Tag




LF82_119 phage NinH protein Escherichia 92.9 19.6
LF82_121 Holin–pore forming protein E. coli, Salmonella enterica subsp. Enterica, S. ﬂexneri
bacteriophage
62.8 6.8
LF82_126 hypothetical protein E. coli, Shigella 111.6 13.2
LF82_134 Phage head assembly protein E. coli, Salmonella, S. ﬂexneri 47.1 6.6
LF82_135 DNA transfer protein E. coli, Salmonella, Shigella, Cronobacter bacteriophage 109.7 7.0
LF82_2871 ydiE inorganic ion transport and
metabolism
E. coli 44.2 47.4
doi:10.1371/journal.pone.0130902.t002
Table 3. Selected common up-regulated and down-regulated biological pathways in LF82 at 2h and
24h time points. For more comprehensive lists of up-regulated and down-regulated pathways at 2h and 24h
please see S2A and S2B Table. The false discovery rate (FDR) is indicated for both the 2h and 24h cultures.
GO–
ID
Pathway Genes at 24h time point 2h FDR 24h
FDR
Up-regulated pathways
41 Transition metal transport 0.0017 0.0045
COPA|FIU|FEPA|FEOB|FES|FEPE|RCNA|YCDO|ZNUA|YCDB|MODC|
CUSC|YDAN|CUSB
9247 Siderophore metabolic process 0.00035 0.0020
ENTE|ENTF|ENTC|YBDZ|ENTA|FES|ENTB
Down-regulated pathways
5977 Glycogen metabolic process 0.0031 0.043
GLGS|GLGC|GLGA|GLGX|GLGP
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Selection of candidate AIEC signature transcripts
To identify candidate AIEC signature transcripts, we took a subtractive approach to identify
coding DNA sequences that were present in the genome of the reference AIEC strain LF82 but
not homologous to sequences in 11 non-invasive E. coli strains. In addition to the HS and
MG1655 strains, we included 9 strains from patients with and without IBD and phenotyped
with respect to their inability to invade epithelial cells and survive within macrophages.
Although five of the non-invasive strains were isolated from non-IBD patients, four others
were isolated from IBD patients (2 UC, 2 CD) (Table 1). Of the 4508 predicted CDS in the
LF82 genome [37], 3446 could be uniquely mapped to corresponding CDS with 85%
sequence identity in the control HS genome. Although 747 LF82 CDS lacked homology to the
Fig 1. Functional modules differentially expressed in strain LF82 compared to non-invasive strain HS at 2h and 24h time points. As mentioned
above, the differences can not be related to the duration of culture vs. the agitation. Functional modules were obtained from a high quality set of protein-
protein interaction previously defined for E. coli [36]. Node size indicates fold change (log2) of differential expression (DE) based on the DESeq algorithm
[33]. Node color indicates direction of regulation. Flagella and chemotaxis module: (a) most chemotaxis genes are up-regulated in LF82 relative to HS at 2h
(DE > 3), while at 24h (b), half of the flagella genes are down-regulated in LF82 (DE > 2). (c) Most nitrate reductase genes are down-regulated in LF82 at 2h
(DE > 2). (d) At 2 hours, iron-sulphur cluster assembly genes in LF82 are down-regulated (DE > = 2.7), and enterobactin synthesis genes (involved in iron
transport) are up-regulated (DE > = 2.3).
doi:10.1371/journal.pone.0130902.g001
Candidate Signature AIEC Transcripts
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HS genome [36] further subtraction was accomplished by including 10 additional NIEC. In the
final analysis, 166 CDS in LF82 were absent from all 11 NIEC genomes.
We compared the 166 CDS across six published AIEC genomes (UM146, NRG857c,
HM605, 541–1, 541–15, 576–1) and six MS AIEC strains (MS-107-1, MS-115-1, MS-119-1,
MS124-1, MS145-7, MS57-2). None of the 166 CDS were homologous to all 13 human AIEC
genomes (see S1 Table). The CDS LF82_95, which encodes an excisionase, was the most preva-
lent with homology in 9 of 13 AIEC genomes (see Table 4 and S1 Table). This CDS also shared
homology with a number of pathogenic E. coli, particularly DEC (see S1 Table). The CDS
LF82_332 corresponds to the pduC gene and was homologous with 6 of 13 AIEC. We also
selected 4 CDS (LF82_089, LF82_091, LF82_091, LF82_092, and LF82_093) that mapped to a
region previously described as “specific region 6” [37] and corresponded to 4 CRISPR-Cas
genes. Three AIEC (LF82, NRG857c, and MS-57-2) shared homologous CDS with all 6 candi-
date AIEC transcripts. Three AIEC strains 541_1, 576_1, and MS–115–1), shared only the
pduC gene and 3 additional AIEC strains (UM146, HM605, and MS-145-7) shared only the 4
Cas genes.
To test the in silico results and validate the PCR primers we amplified DNA for each of the 4
candidate genes (S1 Table). Agarose gel electrophoresis of PCR reactions verified amplification
products of the expected sizes (see methods) for candidate genes LF82_091, LF82_092,
LF82_093 and LF82_088 in strains LF82, MS145-7, and MS57–2 (S2 Table). All other strains,
including MG1655, HS and the 4 MS AIEC strains without homologous Cas genes, exhibited
no PCR amplification with these primers. All samples produced the expected band at 340 base
pairs for the E. coli 16S rRNA gene product (S1 & S2 Figs).
Screening Candidate Gene Transcripts in Human Clinical Specimens
RNA was isolated from fecal samples collected from 53 individuals at Stony Brook University.
Within this collection, 43 (81.1%) stool samples were acquired from children (Table 3).
Twenty-two were IBD patients and 31 individuals were non-IBD controls. Non-IBD patients
included subjects with functional GI disorders, Celiac disease, lactose intolerance and one
patient with juvenile polyps. The number of male patients was significantly higher in both IBD
cohorts compared to controls, p = 0.009 and 0.029 for CD and UC respectively. CD patients
were significantly older (p = 0.024). The median ages for CD, UC/IC and controls were 20, 16
and 15 years, respectively. The IBD patients included 14 patients with CD, 6 patients with UC
and 2 with indeterminate colitis (IC). Three of the CD patients were diagnosed at enrollment.
Parallel ileal biopsies were available for 10 CD patients, 3 UC patients and 23 non-IBD con-
trols. Table 5 displays the characteristics of all subjects. For IBD patients, age of diagnosis, dis-
ease location and disease behavior (CD) are as defined by the Montreal classification[60]. Also
included are disease duration, body mass index (BMI), smoking, surgical management of IBD,
and IBD medications.
To compare the relative abundance of E. coli between clinical specimens, we performed RT-
qPCR with E. coli-specific 16S rRNA gene primers and normalized results to total bacterial 16S
rRNA gene expression (Tables 6 & 7). The median ΔCT values (Total-E. coli Ct) among CD,
UC/IC and non-IBD fecal samples were -14.40, -7.14, and -13.56, respectively. There was no
statistically significant difference in E. coli abundance compared to non-IBD controls. Among
ileal biopsy specimens, the mean ΔCT values for CD, UC/IC and non-IBD samples were -9.94,
-10.50, and -11.84, respectively. There was no statistically significant elevation in E. coli abun-
dance in IBD specimens compared to controls.
The threshold of detection of transcripts corresponding to excisionase (LF82_095), pduC
(LF82_332) and four Cas homologous genes (LF82_088, LF82_091, LF82_092, and LF82_093
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Table 4. LF82 transcripts that share homology with at least 4 other AIEC genomes but none of the 11 NIEC genomes. (See also S3 Table). Putative
protein function is based on sequence homology as listed in NCBI GENE. The mean RPKM are show in the 2h and 24 h LF82 cultures. The number of AIEC
strains (total of 13) with CDS sharing >85% sequence homology is listed. The genes selected for exploratory RT-qPCR analysis of patient samples are in
bold.
RefSeq ID Putative protein 2h RPKM 24h RPKM No. AIEC
LF82_095 excisionase 10.3 8.4 9
LF82_088 CRISPR/Cas system-associated protein Cas1 11.3 28.3 6
LF82_089 CRISPR/Cas system-associated protein Cas3/Cas2 22.2 39.9 6
LF82_092 CRISPR/Cas system-associated RAMP superfamily protein Csy3 29.5 31.8 6
LF82_093 CRISPR/Cas system-associated RAMP superfamily protein Cas6f 12.0 9.7 6
LF82_328 cobalamin biosynthesis protein CbiG 16.7 13.0 6
LF82_330 propanediol diffusion facilitator 0.7 3.3 6
LF82_331 propanediol utilization protein:polyhedral bodies 0.2 0.7 6
LF82_332 propanediol utilization protein: glycerol dehydratase large subunit (pduC) 0.5 2.4 6
LF82_333 propanediol utilization protein: diol dehydratase medium subunit 1.1 4.0 6
LF82_334 propanediol utilization protein: diol dehydratase small subunit 0.6 1.3 6
LF82_335 propanediol utilization protein: diol dehydratase reactivation 0.6 2.8 6
LF82_336 propanediol utilization protein: diol dehydratase reactivation 1.4 3.3 6
LF82_337 propanediol utilization protein: polyhedral bodies 9.1 13.6 6
LF82_338 propanediol utilization protein: polyhedral bodies 1.0 2.3 6
LF82_339 propanediol utilization protein 0.5 3.5 6
LF82_340 propanediol utilization protein 1.4 5.5 6
LF82_341 propanediol utilization protein: polyhedral bodies 1.1 2.9 6
LF82_342 propanediol utilization protein: B12 related 1.5 2.9 6
LF82_343 CoAdependent proprionaldehyde dehydrogenase 2.1 4.5 6
LF82_344 propanediol utilization protein: propanol dehydrogenase 0.6 0.9 6
LF82_345 propanediol utilization protein 1.0 2.9 6
LF82_346 propanediol utilization protein: polyhedral bodies 2.1 4.1 6
LF82_347 propanediol utilization protein: polyhedral bodies 2.2 3.5 6
LF82_778 putative propanediol utilization protein 0.2 3.4 6
LF82_013 hypothetical protein 12.8 12.5 5
LF82_090 hypothetical protein 17.7 13.2 5
LF82_199 iron compound ABC transporter 0.2 0.9 5
LF82_348 propanediol utilization protein 3.8 6.1 5
LF82_091 CRISPR-associated protein (Cas_Csy2) 14.4 6.2 4
LF82_329 Pdu/cob regulatory protein 7.3 10.8 4
LF82_389 variable tail ﬁbre protein 0.7 3.2 4
LF82_441 hypothetical protein 9.1 21.9 4
LF82_548 major ﬁmbrial subunit 11.3 21.3 4
LF82_550 outer membrane usher protein lpfC precursor 33.1 51.7 4
LF82_551 ﬁmbrial chaperone protein 0.2 0.9 4
LF82_552 ﬁmbrial-like protein 3.6 3.5 4
LF82_723 DHA kinase PgdK (EC 27129) 15.6 16.7 4
LF82_724 dihydroxyacetone kinase PdaK (EC271 29) 1.4 5.4 4
LF82_725 glycerol dehydrogenase CgrD (EC1116) 8.8 5.3 4
LF82_726 transporter CgxT 1.3 2.3 4
LF82_727 dihydrolipoamide dehydrogenase CdlD 3.5 5.4 4
LF82_728 carnitine transporter CniT 3.0 7.9 4
LF82_729 glycerate kinase GclK 2.4 6.6 4
LF82_730 3hydroxyisobutyrate dehydrogenase GhbD(EC 11131) 1.9 2.9 4
(Continued)
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was set at Ct 35. The negative Ct values ranged between 39 and 40. A higher proportion of
CD fecal (Table 6) and ileal (Table 7) cDNA samples were positive for LF82_091 and
Table 4. (Continued)
RefSeq ID Putative protein 2h RPKM 24h RPKM No. AIEC
LF82_731 regulatory protein GclR 1.8 3.1 4
LF82_732 glycoxylate carboligase GclA 0.6 1.7 4
LF82_733 regulatory protein IbgR 4.7 6.0 4
LF82_734 Invasion protein IbeA 2.5 4.5 4
LF82_735 transporter IbgT 1.3 3.0 4
doi:10.1371/journal.pone.0130902.t004
Table 5. Clinical characteristics of CD, UC/IC and non-IBD patients.
CD N = 14 UC/IC N = 8 Non-IBD N = 32
Gender
Male 11 (85%) 7 (88%) 11 (35%)
Age of Diagnosis, (Montreal A)
A1 (16 yr) 71.4 87.5
A2 (17–40 yr) 28.5 12.5
A3 (>40 yr)








Disease Behavior, CD (Montreal B)
B1 nonstricturing, nonpenetrating 57.1
B2 stricturing) 21.4
B3 penetrating—excludes perianal 21.4
Median age at procedure (IQR)a y 20 (14.2–25.7) 16 (12.7–17.2) 15 (11–17)
Median duration of disease (IQR) y 4.5 (1.4–6.8) 1.5 (0–10)
Race
Caucasian 11 (85%) 6 (75%) 28 (88%)
Current Smoker 1 0 1
Median BMI (IQR) kg/m2 21.0 (17–24) 19.8(18.7–22) 20.1(17.5–24.5)
Medications
Mesalamineb 5 (36%) 1 (12%) 0
Steroids 2 (14%) 1 (12%)
Immunomodulatorsc 4 (29%) 1 (12%)
Anti TNF alpha biologicsd 7 (50%) 1 (12%)
aIQR: Interquartile range
bMesalamine: Balsalazide, Mesalamine, Olsalazine, Sulfasalazine
cImmunomodulators: Imuran, Methotrexate
dBiologics: Adalimumab, Certolizumab, Inﬂiximab
doi:10.1371/journal.pone.0130902.t005
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LF82_092 transcripts than non-IBD fecal and ileal RNA samples (p<0.05) A higher propor-
tion of CD fecal samples were positive for LF82_088 in CD vs. non-IBD samples and a higher
proportion of CD ileal samples were positive for LF82_093 AND LF82_095 in CD vs. non-
IBD.
The median ΔCT values (Total-E. coli Ct) among CD, UC/IC and non-IBD fecal samples
were -14.40, -7.14, and -13.56, respectively. There was no statistically significant difference in
E. coli abundance when compared to non-IBD controls. Among ileal biopsy specimens, the
mean ΔCT values for CD, UC/IC and non-IBD samples were -9.94, -10.50, and -11.84, respec-
tively. There was no statistically significant elevation in E. coli abundance in IBD specimens
compared to controls.
Discussion
Although a higher proportion of CD patients harbor AIEC, such organisms can also be recov-
ered from non-IBD patients. Conversely, NIEC strains are recovered from IBD patients
(Table 1). The pathogenic potential of AIEC may vary depending on host susceptibility. Host
factors such as IBD risk alleles and Paneth cell function have been linked to alterations in ileal
mucosa-associated microbial composition and the Escherichia/Shigella genus [12, 14, 57, 61,
Table 6. Fecal RT-qPCR results for candidate AIEC transcripts. The number of positive fecal stool samples are shown for each candidate AIEC tran-
script. Transcript is defined by LF82 locus tag and hypothetical function. Fisher’s exact tests were used to compare the frequencies of positive results. “*” rep-
resents P values of <0.05. The median ΔCtE. coli (range) is shown. The nonparametric Mann-Whitney test was used to compare values for IBD compared to
non-IBD and CD compared to non-IBD for fecal and ileal biopsy samples, respectively.
Transcript CD UC/IC Non-IBD P value P-value
N = 14 N = 8 N = 32 IBD vs. non-IBD CD vs. Non-IBD
LF82_095 excisionase 9 4 14 0.41 0.34
LF82_332 pduC 3 3 8 1.00 1.00
LF82_088 cas1_I-F 5 1 2 0.05 0.02*
LF82_091 cas_Csy2 5 1 2 0.05 0.02*
LF82_092 csy3_I-F 5 1 2 0.05 0.02*
LF82_093 cas6_I-F 1 0 1 1.00 0.52
Median ΔCtE. coli (IQR) -14.4 -7.4 -13.6 0.48 0.81
(-17.54 to -11.85) (-12.81 to -4.80) (-18.10 to -11.41)
doi:10.1371/journal.pone.0130902.t006
Table 7. Ileal RT qPCR results for candidate AIEC transcripts. The number of positive ileal biopsy samples are shown for each candidate AIEC transcript.
Transcript is defined by LF82 locus tag and hypothetical function. Fisher’s exact tests were used to compare the frequencies of positive results. “*” represents
P values of <0.05. The median ΔCtE. coli (interquartile range) is shown. The nonparametric Mann-Whitney test was used to compare values for IBD compared
to non-IBD and CD compared to non-IBD for fecal and ileal biopsy samples, respectively.
Transcript CD UC/IC Non-IBD P value P-value
N = 12 N = 3 N = 23 IBD vs. non-IBD CD vs. non-IBD
LF82_095 excisionase 4 0 0 0.74 .0095*
LF82_332 pduC 2 0 1 0.55 0.27
LF82_088 cas1_I-F 9 2 11 0.09 0.16
LF82_091 cas_Csy2 6 0 3 0.12 0.04
LF82_092 csy3_I-F 6 0 3 0.12 0.04
LF82_093 cas6_I-F 3 0 0 0.05 0.03
Median ΔCtE. coli (IQR) -9.9 -10.5 -11.8 0.08 0.12
(—11.92 to -7.35) (-10.89 to -6.83) (-16.56 to -9.60)
doi:10.1371/journal.pone.0130902.t007
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62]. In-vitro analysis has not been performed for many human commensal E. coli strains. In
this study the complete genomes for 13 AIEC and 11NIEC, all with prior in-vitro phenotypic
analysis were compared.
Multiple studies have demonstrated that CD patients, particularly those with ileal disease,
have altered intestinal microbial biodiversity and composition. Because most of these studies
are based on 16S rRNA sequence analysis, they do not address alterations in microbial func-
tion, or in subgroups within identified species. Shotgun bacterial DNAmetagenomics and bac-
terial metatranscriptomics measure alterations in microbial function more directly than does
16S rRNA sequence analysis. The advantage of bacterial transcriptomic data over shotgun
metagenomics data is that the former provides information on which bacterial genes are actu-
ally transcribed. In this study we compared the transcriptomes of a reference AIEC strain,
LF82 to a control strain HS to identify genes associated with the AIEC phenotype. We selected
HS as the control strain which was previously demonstrated to be non-invasive [28].
A comparative analysis of genes shared between the LF82 and HS genomes indicated that
many of the DEG had a relatively low fold change (~ 2–4 fold) making them less suited for clin-
ical assays. Up-regulated genes in LF82 are involved in many key pathways including iron
metabolism, supporting the recent report that AIEC strains are enriched for genes involved in
iron utilization [37], a feature of many B2 phylotype members. Comparison of the transcrip-
tional profiles revealed a significant effect of growth conditions (see Fig 1). We identified six
genes with no detectable expression in HS (Table 2) at both growth conditions. Four of the
genes code for identical proteins in the enteropathogenic bacteria Salmonella and Shigella. Fur-
ther characterization of these proteins in AIEC and non-invasive E. coli strains is necessary to
determine if they are a component of the AIEC phenotype.
In the comparative analysis of RNA-seq data, 747 CDS that mapped to the LF82 genome
did not share homology with CDS in HS (S1 Table). We extended our comparative analysis to
13 E. coli strains with the AIEC pathotype and 11 NIEC (Table 1). Using a subtractive geno-
mics approach, we found that the 166 CDS present only in LF82 were not homologous in all 11
NIEC (S1 Table). However, none of the 166 CDS were present in the 13 AIEC strains surveyed.
This observation supports the concept that the AIEC pathovar is formed by a heterogeneous
collection of serogroups and serotypes. As shown in Table 3, AIEC genomes are enriched in
genes belonging to the pdu operon, the ibe operon, and the type VI secretion system [34, 37,
38]. The pdu operon is a component of a metabolic pathway required for fucose utilization
[63], and is present in enterpathogenic bacteria and offers a competitive advantage for energy
production under anaerobic conditions [34, 63]. The ibeA gene (invasion of brain endothe-
lium) encodes an invasion protein found in several extraintestinal pathogenic E. coli (ExPEC)
strains[64]. This gene may also play a role in E. coli resistance to H2Os stress [65]. IbeA is a nec-
essary component for invasion of IECs and absence or mutation of this gene limits survival of
AIEC within macrophage[66]. The type VI secretion system has been implicated in targeting
other bacterial and eukaryotic cells [67]. We found homologous CDS for chuA and yersiniabac-
tin, in 6 of 11 NIEC. These iron uptake genes are enriched among AIEC strains [37] and other
pathogenic E. coli including ExPEC and EHEC. However, it remains to be determined whether
these genes are expressed in the noninvasive strains. This analysis is limited by the fact that
growth in pure cultures represents a very different environment than within the human intes-
tine, and thus does not take into consideration complex microbe-microbe and host-microbe
interactions. In addition, our subtractive genomics approach was limited to CDS expressed in
the reference AIEC strain LF82. NRG857C has a genome that is highly similar to LF82 how-
ever, CDS in NRG857C but absent in LF82 were present in as many as six of the 13 other AIEC
strains. Additional CDS that were homologous among three or more AIEC except LF82 and
absent in the 11 NIEC are listed in S3 Table. Nonetheless, the results of this analysis provide a
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useful baseline repertoire of E. coli transcriptional patterns that may aid in the analysis of com-
plex patient based metatranscriptomic data.
Among the 166 CDS mapping to the LF82 genome, we identified four potential signature
transcripts belonging to CRISPR-associated (Cas) genes. These genes map to a region of the
LF82 genome that is highly specific [37] and in our analysis these CDS were conserved in 4 of 6
AIEC strains. We did not find homologous CDS in DEC, although they are homologous to
CDS in three ExPEC. Among the strains with these specific Cas genes, four of the AIEC strains
and the three ExPEC are of the B2 phylotype. AIEC of the B2 phylotype are described to be
among the most abundant and the most virulent [68]. CRISPR-Cas forms the adaptive immu-
nity system [69–71]. Bacterial strains express Cas proteins that recognize foreign genetic ele-
ments in plasmids and phages and insert fragments of the exogenous DNA into their own
genomes. Most E. coli harbor CRISPR-Cas systems that belong to subtype I-E [72]. LF82 has
the I-F system which has 3 CRISPR arrays and an operon of 6 cas-F genes (cas6f, csy3, csy2,
csy1, cas2, cas3, and cas1) [72]. This system is also found in Yersinia pestis an enterotoxigenic
E. coli (strain B7A) and a subset of B2 phylotype E. coli [72]. Toro et al, [73] examined the rela-
tionship between CRISPR-Cas systems and virulence in Shiga toxin-producing E. coli (STEC)
and observed conservation of CRIPR spacer contents among strains of the same serotype and
that the highly virulent STEC strains had fewer spacers within CRISPR arrays. Two other
groups have recently identified CRISPR-Cas gene loci for the development of serotype-specific
PCR assays of STEC [74, 75] and Salmonella enterica serotypes Typhi and Paratyphi A [76].
We analyzed 53 fecal samples (Table 6) using 4 Cas gene assays and 35.7% of CD compared
to 6.2% of non-IBD control samples (p = 0.02) revealed positive assays for 3 of the 4 assays.
Using the pduC primers described in Dogan et al[34], expression of the pduC gene was detected
in 21.4% CD compared to 25% of non-IBD controls (p = 1.0). For the excisionase gene 64% of
CD compared to 44% of non-IBD control samples (p = 0.34) had positive assays. We also ana-
lyzed 38 parallel ileal biopsy samples (Table 7) and 50% of CD compared to 13% of non-IBD
control samples (p = 0.04) had positive assays. Expression of the pduC gene was detected in
17% CD compared to 4% of non-IBD controls (p = 0.27). For the excisionase gene 33% of CD
compared to 0% of non-IBD control samples (p = 0.0095) had positive assays. All 4 excisionase
positive samples were correspondingly positive for Cas genes. The p-values for the Cas assays
did not reach significance after applying the Bonferroni correction for multiple comparisons
(p<0.01). Nevertheless we observed a similar trend in fecal and/or ileal biopsies for all four of
the Cas genes tested. Our data suggests the Cas genes may serve as promising AIEC biomark-
ers; this will need to be confirmed in a larger set of patient samples. We did not detect a signifi-
cant difference in E. coli 16S rRNA gene expression (ΔCT) relative to total bacteria in cases
compared to non-IBD controls.
Altogether our sample sizes were small and pduC expression was less discriminating for
AIEC infected samples. However, it may be a useful target for therapeutic intervention as previ-
ously described. It is also possible that other pdu operon genes are more specific and could
serve as better targets. Our study is consistent with other reports that no single gene is able to
distinguish AIEC from NIEC. Furthermore, it remains to be demonstrated whether any candi-
date AIEC signature transcripts with utility as a microbial biomarker, has a functional role in
pathogenicity.
In summary, these results identify potential candidate AIEC signature transcripts, which
may be more prevalent among CD patients than non-IBD patients and serve as proof of princi-
ple for our comparative genomic/transcriptomic analysis of AIEC and NIEC.
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Supporting Information
S1 Fig. Specific CAS genes are detected in AIEC by PCR. Agarose gel electrophoresis analysis
of PCR products obtained from reactions using forward and reverse primers of the Cas genes
LF82_091 and LF82_092, with E. coli 16S rRNA as a positive control. Positions of molecular
size standards (in bp) are indicated, also see methods.
(TIF)
S2 Fig. Specific CAS genes are detected in AIEC by PCR. Agarose gel electrophoresis analysis
of PCR products obtained from reactions using forward and reverse primers of the Cas genes
LF82_088 and LF82_093, with E. coli 16S as a positive control. Positions of molecular size stan-
dards (in bp) are indicated, also see methods.
(TIF)
S1 File. Up-regulated and Down regulated transcripts in LF82 and HS. Table A. Up-regu-
lated transcripts in LF82 compared to HS. RNA was extracted from bacteria at exponential
(2h) and stationary (24h) phases of growth in pure cultures and RNA sequencing completed.
Expression level of homologous CDS in LF82 and HS is compared at 2 h, 24h and at both time
points using edgeR. Up-regulated CDS with fold change 2, FDR<0.05. The RPKM values
for LF82 and HS are shown. Table B. Down-regulated transcripts in LF82 compared to HS
cultures. RNA was extracted from bacteria at exponential (2h) and stationary (24h) phases of
growth in pure cultures and RNA sequencing completed. Expression level of homologous CDS
in LF82 and HS is compared at 2 h, 24h and at both time points using edgeR. Up-regulated
CDS with fold change 2, FDR<0.05. The RPKM values for LF82 and HS are shown.
(XLSX)
S2 File. GO functional categories in LF82 and HS. Table A. Up-regulated GO-categories
(FDR<0.05) in LF82 compared to HS cultures at 2h. Table B. Up-regulated GO-categories
(FDR< 0.05) in LF82 compared to HS cultures at 24h. Table C. Down-regulated GO categories
(FDR<0.05) in LF82 compared to HS cultures at 2h. Table D. Down-regulated GO categories
(FDR<0.05) in LF82 compared to HS cultures at 2h.
(XLSX)
S1 Table. LF82 transcripts that lack homology (< 85% sequence identity) within 11 non-
invasive E. coli strains.
(XLSX)
S2 Table. Forward and reverse primers for RT-qPCR assays.
(DOCX)
S3 Table. AIEC genes that do not share sequence homology (<85% sequence identity) with
LF82 or non-invasive E. coli strains.
(XLSX)
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